MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Wearable versus marker-free technologies: does it matter for clinical gait analysis?

    K. Otte, D. Drebinger, H. Röhling, T. Vater, D. Kroneberg, M. Voigt, B. Kayser, S. Mansow-Model, AU. Brandt, F. Paul, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)

    Objective: To compare wearable sensor-based and marker-less 3D video-based gait analysis in two neurodegenerative disorders associated with gait dysfunction. Background: Quantitative gait analysis supports diagnosis…
  • 2019 International Congress

    Effect of Medication Review on Reported Symptoms in Parkinson’s disease Patients

    C. Stuijt, T. Laar (Groningen, Netherlands)

    Objective: The objective was to analyse the effect of structured medication reviews (MR) in ambulatory PD patients on patient reported outcome measures (PROMS). Background: Patients…
  • 2019 International Congress

    Сhange In The Body Composition Of Patients With Parkinsonism For 2 Years

    D,A. Akramova, G. Rakhimbaeva, D. Bobomuratova (Tashkent, Uzbekistan)

    Objective: The body composition of Parkinson’s disease patients is undergoing changes due to less physical activity, stress. Background: To determine the changes in body structure…
  • 2019 International Congress

    Improving outcomes in hospitalized Parkinson’s patients

    S. Aslam, E. Simpson, M. Baugh, H. Shill (Phoenix, AZ, USA)

    Objective: Evaluate an inpatient intervention to reduce rates of hospital related complications in hospitalized patients with Parkinson’s disease (PD). Background: Several interventions have been suggested…
  • 2019 International Congress

    Characteristics and outcome of patients with Parkinson’s disease admitted to intensive care unit

    O. Benhadj Salem, S. Demeret, A. Demoule, F. Bolgert, H. Outin, T. Sharshar, D. Grabli (Paris, France)

    Objective: To study the characteristics and the outcome of patients with Parkinson's disease admitted to intensive care unit. Background: Whereas Parkinson’s disease is associated with…
  • 2019 International Congress

    Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations

    P. Campbell, J. Harvey, A. Costantini, H. Morris, A. Schapira (London, United Kingdom)

    Objective: To investigate the use of PBMCs as a biomarker of mitochondrial dysfunction in Parkinson disease (PD) patients carrying pathogenic parkin or LRRK2 mutations. Background:…
  • 2019 International Congress

    Genomic variants associated with cognitive impairment in Parkinson’s disease: Ethnicity-specific GWAS

    SJ. Chung, N. Choi, J. Kim, K. Kim, MJ. Kim, YJ. Kim, HS. Ryu, KW. Park (Anyang, Republic of Korea)

    Objective: We aimed to identify the genomic variants that are associated with cognitive impairment in patients with Parkinson’s disease (PD). Background: Cognitive impairment is an…
  • 2019 International Congress

    Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice

    M. Dean, M. Patel, K. Barnes, D. Standaert (Birmingham, AL, USA)

    Objective: To describe and compare characteristics of African American (AA) and White Parkinson’s Disease (PD) patients seen in a large clinic practice at the University…
  • 2019 International Congress

    Pattern and Presentation of Parkinson Disease in two Teaching Hospitals in Enugu, South East Nigeria

    B. Ezeala-Adikaibe (Enugu, Nigeria)

    Objective: To describe the pattern of presentation of Parkinson disease in patients attending medical out-patient clinic in Enugu South East Nigeria. Background: Parkinson Disease is…
  • 2019 International Congress

    DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease

    Z. Guduru, D. Ginjupally, T. Ali, N. El Seblani, J. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: Deep brain stimulation (DBS) targeting Globus pallidus pars interna (GPi) and subthalamic nucleus (STN) is an established surgical treatment for Parkinson’s disease (PD). Due…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley